ITeos Therapeutics

ITOSNASDAQ
$14.78
0.342.35%
At Close: -
$14.52
-0.26-1.76%
After Hours: 9:02 AM EDT
15 minutes delayed

ITeos Therapeutics (NASDAQ:ITOS) Stock, Insider Trading Activity

ITeos Therapeutics: Insider buying and selling updated today.

Institutional Shares Held
10.289M
Institutional Percentage Held
28.6%
Oct 12, 2023Matthew GallCHIEF FINANCIAL OFFICER5K$8.37$41.85KBUY34.65%19.429KOct 12View
Aug 25, 2023Boxer Capital LLCBoxer Asset Management IncJOSEPH LEWISAaron Davis—-350K$16.26-$5.69MSELL-16.25%1.804058MAug 23View
Jun 10, 2022David HallalDIRECTOR0$11.94-$487.17KSELL-OPTIONS0.00%0Jun 08 - Jun 09View
May 11, 2022Aaron I DavisDIRECTOR-663K$21.04-$13.95MSELL-23.54%2.154058MMay 09 - May 11View
May 02, 2022Aaron I DavisDIRECTOR-375K$27.33-$10.25MSELL-11.75%2.817058MApr 28 - May 02View
Apr 19, 2022Michel DetheuxCHIEF EXECUTIVE OFFICER0$18.05-$317.89KSELL-OPTIONS0.00%26.263KApr 18View
Mar 24, 2022Aaron I DavisDIRECTOR50K$32.51$1.63MBUY1.59%3.192058MMar 22 - Mar 23View
Mar 22, 2022Michel DetheuxCHIEF EXECUTIVE OFFICER-18.437K$34.17-$629.99KSELL-41.25%26.263KMar 22View
Mar 18, 2022Boxer Capital LLCBoxer Asset Management IncJOSEPH LEWIS10% OWNER-575.201K$35.25-$20.28MSELL-15.47%3.142058MMar 17View
Mar 14, 2022Jenkins Joanne LagerCHIEF MEDICAL OFFICER0$20.15-$110.98KSELL-OPTIONS0.00%0Mar 11View
Mar 02, 2022Yvonne McGrathCHIEF SCIENTIFIC OFFICER0$20.50-$325.17KSELL-OPTIONS0.00%0Mar 01View
Feb 24, 2022Michel DetheuxCHIEF EXECUTIVE OFFICER-14.5K$34.34-$497.90KSELL-29.47%34.7KFeb 23View
Feb 14, 2022Jenkins Joanne LagerCHIEF MEDICAL OFFICER0$20.07-$110.41KSELL-OPTIONS0.00%0Feb 11View
Jan 26, 2022Michel DetheuxCHIEF EXECUTIVE OFFICER-14.5K$35.68-$517.38KSELL-22.76%49.2KJan 25View
Jan 18, 2022Jenkins Joanne LagerCHIEF MEDICAL OFFICER0$21.81-$122.56KSELL-OPTIONS0.00%0Jan 14View
Jan 06, 2022MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-146.685K$42.58-$6.25MSELL-5.08%2.738785MJan 04 - Jan 05View
Jan 06, 2022MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-146.685K$42.58-$6.25MSELL-5.08%2.738785MJan 04 - Jan 05View
Jan 06, 2022ANSBERT GADICKEUBS Oncology Impact Fund LPBioImpact Capital LLCOncology Impact Fund Cayman Management LP10% OWNER-245.469K$42.58-$10.45MSELL-5.19%4.484728MJan 04 - Jan 05View
Jan 05, 2022Boxer Capital LLCBoxer Asset Management IncJOSEPH LEWISMVA Investors LLCAaron DavisDIRECTOR-700K$46.54-$32.58MSELL-100.00%0Jan 03 - Jan 04View
Jan 04, 2022Jenkins Joanne LagerCHIEF MEDICAL OFFICER0$28.10-$333.20KSELL-OPTIONS0.00%0Jan 03View
Jan 04, 2022Detlev BiniszkiewiczDIRECTOR0$35.45-$115.15KSELL-OPTIONS0.00%0Jan 03View
Dec 28, 2021Matthew GallCHIEF FINANCIAL OFFICER-5K$46.45-$232.25KSELL-25.73%14.429KDec 27View
Dec 22, 2021Michel DetheuxCHIEF EXECUTIVE OFFICER-14.5K$24.42-$1.85MSELL-18.54%63.7KDec 20 - Dec 22View
Dec 22, 2021David HallalDIRECTOR0$23.53-$2.00MSELL-OPTIONS0.00%0Dec 20View
Dec 17, 2021Jenkins Joanne LagerCHIEF MEDICAL OFFICER0$22.65-$256.90KSELL-OPTIONS0.00%0Dec 17View
Dec 10, 2021Jenkins Joanne LagerCHIEF MEDICAL OFFICER0$19.40-$105.70KSELL-OPTIONS0.00%0Dec 10View
Dec 07, 2021MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-49.831K$33.73-$1.68MSELL-1.70%2.88547MDec 03 - Dec 07View
Dec 07, 2021MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-49.831K$33.73-$1.68MSELL-1.70%2.88547MDec 03 - Dec 07View
Dec 07, 2021ANSBERT GADICKEUBS Oncology Impact Fund LPBioImpact Capital LLCOncology Impact Fund Cayman Management LP10% OWNER-83.39K$33.73-$2.81MSELL-1.73%4.730197MDec 03 - Dec 07View
Dec 02, 2021MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-83.519K$34.47-$2.88MSELL-2.77%2.935301MNov 30 - Dec 02View
Dec 02, 2021MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-83.519K$34.47-$2.88MSELL-2.77%2.935301MNov 30 - Dec 02View
Dec 02, 2021ANSBERT GADICKEUBS Oncology Impact Fund LPBioImpact Capital LLCOncology Impact Fund Cayman Management LP10% OWNER-139.773K$34.47-$4.82MSELL-2.82%4.813587MNov 30 - Dec 02View
Nov 30, 2021MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-23.045K$35.18-$810.77KSELL-0.76%3.01882MNov 26 - Nov 29View
Nov 30, 2021MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-23.045K$35.18-$810.77KSELL-0.76%3.01882MNov 26 - Nov 29View
Nov 30, 2021ANSBERT GADICKEUBS Oncology Impact Fund LPBioImpact Capital LLCOncology Impact Fund Cayman Management LP10% OWNER-38.566K$35.18-$1.36MSELL-0.77%4.95336MNov 26 - Nov 29View
Nov 24, 2021Michel DetheuxCHIEF EXECUTIVE OFFICER1.763K$24.27-$320.69KSELL-OPTIONS2.31%78.2KNov 22 - Nov 23View
Nov 24, 2021ANSBERT GADICKEUBS Oncology Impact Fund LPBioImpact Capital LLCOncology Impact Fund Cayman Management LP10% OWNER-145.288K$36.61-$4.74MSELL-2.83%4.991926MNov 17 - Nov 24View
Nov 24, 2021MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-93.126K$36.61-$2.84MSELL-2.97%3.041865MNov 17 - Nov 24View
Nov 24, 2021MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-93.126K$36.61-$2.84MSELL-2.97%3.041865MNov 17 - Nov 24View
Nov 19, 2021Jenkins Joanne LagerCHIEF MEDICAL OFFICER0$19.40-$845.60KSELL-OPTIONS0.00%0Nov 18View
Nov 03, 2021Michel DetheuxCHIEF EXECUTIVE OFFICER-20.557K$28.55-$586.97KSELL-21.19%76.437KNov 01 - Nov 03View
Oct 25, 2021Michel DetheuxCHIEF EXECUTIVE OFFICER-196$28.00-$5.49KSELL-0.20%96.994KOct 21View
Oct 19, 2021Michel DetheuxCHIEF EXECUTIVE OFFICER-1.836K$28.01-$51.42KSELL-1.85%97.19KOct 15 - Oct 19View
Oct 18, 2021MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-17.099K$27.45-$469.31KSELL-0.54%3.134991MOct 15 - Oct 18View
Oct 18, 2021MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-17.099K$27.45-$469.31KSELL-0.54%3.134991MOct 15 - Oct 18View
Oct 18, 2021ANSBERT GADICKEUBS Oncology Impact Fund LPBioImpact Capital LLCOncology Impact Fund Cayman Management LP10% OWNER-28.615K$27.45-$785.38KSELL-0.55%5.137214MOct 15 - Oct 18View
Oct 14, 2021MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-56.77K$27.21-$1.54MSELL-1.77%3.15209MOct 12 - Oct 14View
Oct 14, 2021MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-56.77K$27.21-$1.54MSELL-1.77%3.15209MOct 12 - Oct 14View
Oct 14, 2021ANSBERT GADICKEUBS Oncology Impact Fund LPBioImpact Capital LLCOncology Impact Fund Cayman Management LP10% OWNER-95.002K$27.21-$2.58MSELL-1.81%5.165829MOct 12 - Oct 14View
Oct 12, 2021MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-51.993K$27.23-$1.42MSELL-1.59%3.20886MOct 07 - Oct 11View
Oct 12, 2021MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-51.993K$27.23-$1.42MSELL-1.59%3.20886MOct 07 - Oct 11View
Oct 12, 2021ANSBERT GADICKEUBS Oncology Impact Fund LPBioImpact Capital LLCOncology Impact Fund Cayman Management LP10% OWNER-87.006K$27.23-$2.37MSELL-1.63%5.260831MOct 07 - Oct 11View
Oct 05, 2021MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-27.566K$27.05-$745.52KSELL-0.84%3.260853MOct 01 - Oct 04View
Oct 05, 2021MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-27.566K$27.05-$745.52KSELL-0.84%3.260853MOct 01 - Oct 04View
Oct 05, 2021ANSBERT GADICKEUBS Oncology Impact Fund LPBioImpact Capital LLCOncology Impact Fund Cayman Management LP10% OWNER-46.13K$27.05-$1.25MSELL-0.86%5.347837MOct 01 - Oct 04View
Sep 30, 2021MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-21.506K$27.00-$580.66KSELL-0.65%3.288419MSep 28 - Sep 30View
Sep 30, 2021MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-21.506K$27.00-$580.66KSELL-0.65%3.288419MSep 28 - Sep 30View
Sep 30, 2021ANSBERT GADICKEUBS Oncology Impact Fund LPBioImpact Capital LLCOncology Impact Fund Cayman Management LP10% OWNER-35.99K$27.00-$971.73KSELL-0.66%5.393967MSep 28 - Sep 30View
Sep 27, 2021Michel DetheuxCHIEF EXECUTIVE OFFICER-6.411K$28.14-$180.37KSELL-6.08%99.026KSep 23 - Sep 24View
Sep 27, 2021MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-53.468K$27.76-$1.48MSELL-1.59%3.309925MSep 23 - Sep 27View
Sep 27, 2021MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-53.468K$27.76-$1.48MSELL-1.59%3.309925MSep 23 - Sep 27View
Sep 27, 2021ANSBERT GADICKEUBS Oncology Impact Fund LPBioImpact Capital LLCOncology Impact Fund Cayman Management LP10% OWNER-89.476K$27.76-$2.48MSELL-1.62%5.429957MSep 23 - Sep 27View
Sep 23, 2021MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-33.929K$27.50-$933.03KSELL-1.00%3.363393MSep 21 - Sep 22View
Sep 23, 2021MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-33.929K$27.50-$933.03KSELL-1.00%3.363393MSep 21 - Sep 22View
Sep 23, 2021ANSBERT GADICKEUBS Oncology Impact Fund LPBioImpact Capital LLCOncology Impact Fund Cayman Management LP10% OWNER-56.779K$27.50-$1.56MSELL-1.02%5.519433MSep 21 - Sep 22View
Sep 20, 2021MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-91.254K$28.38-$2.59MSELL-2.62%3.397322MSep 16 - Sep 20View
Sep 20, 2021MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-91.254K$28.38-$2.59MSELL-2.62%3.397322MSep 16 - Sep 20View
Sep 20, 2021ANSBERT GADICKEUBS Oncology Impact Fund LPBioImpact Capital LLCOncology Impact Fund Cayman Management LP10% OWNER-152.711K$28.38-$4.33MSELL-2.67%5.576212MSep 16 - Sep 20View
Sep 16, 2021MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-45.665K$27.70-$1.26MSELL-1.29%3.488576MSep 14 - Sep 15View
Sep 16, 2021MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-45.665K$27.70-$1.26MSELL-1.29%3.488576MSep 14 - Sep 15View
Sep 16, 2021ANSBERT GADICKEUBS Oncology Impact Fund LPBioImpact Capital LLCOncology Impact Fund Cayman Management LP10% OWNER-76.417K$27.70-$2.12MSELL-1.32%5.728923MSep 14 - Sep 15View
Sep 13, 2021ANSBERT GADICKEUBS Oncology Impact Fund LPBioImpact Capital LLCOncology Impact Fund Cayman Management LP10% OWNER-96.456K$28.32-$2.73MSELL-1.63%5.80534MSep 09 - Sep 13View
Sep 13, 2021MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-57.64K$28.32-$1.63MSELL-1.60%3.534241MSep 09 - Sep 13View
Sep 13, 2021MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-57.64K$28.32-$1.63MSELL-1.60%3.534241MSep 09 - Sep 13View
Sep 08, 2021ANSBERT GADICKEUBS Oncology Impact Fund LPBioImpact Capital LLCOncology Impact Fund Cayman Management LP10% OWNER-102.572K$29.03-$2.07MSELL-1.71%5.901796MSep 07 - Sep 08View
Sep 08, 2021MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-73.906K$29.03-$1.24MSELL-2.02%3.591881MSep 07 - Sep 08View
Sep 08, 2021MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-73.906K$29.03-$1.24MSELL-2.02%3.591881MSep 07 - Sep 08View
Sep 03, 2021Michel DetheuxCHIEF EXECUTIVE OFFICER-20.252K$28.66-$580.52KSELL-16.11%105.437KSep 01 - Sep 02View
Aug 31, 2021Michel DetheuxCHIEF EXECUTIVE OFFICER-14.663K$28.13-$412.48KSELL-10.45%125.689KAug 27 - Aug 31View
Aug 25, 2021Michel DetheuxCHIEF EXECUTIVE OFFICER-8.585K$28.06-$240.89KSELL-5.76%140.352KAug 23 - Aug 25View
Jun 16, 2021Michel DetheuxCHIEF EXECUTIVE OFFICER-29K$28.50-$826.53KSELL-16.30%148.937KJun 14View
Jun 16, 2021Matthew GallCHIEF FINANCIAL OFFICER5K$26.09$130.45KBUY∞5KJun 16View
Jun 10, 2021Yvonne McGrathVP, RESEARCH AND DEVELOPMENT0$12.12-$125.01KSELL-OPTIONS0.00%0Jun 08View
Jun 03, 2021Yvonne McGrathVP, RESEARCH AND DEVELOPMENT0$12.20-$126.37KSELL-OPTIONS0.00%0Jun 01 - Jun 02View
May 26, 2021Yvonne McGrathVP, RESEARCH AND DEVELOPMENT0$13.08-$140.27KSELL-OPTIONS0.00%0May 24View
May 19, 2021Yvonne McGrathVP, RESEARCH AND DEVELOPMENT0$14.46-$162.19KSELL-OPTIONS0.00%0May 17View
Apr 13, 2021MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-119$29.99-$3.57KSELL-0.00%3.665787MApr 09View
Apr 13, 2021MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-119$29.99-$3.57KSELL-0.00%3.665787MApr 09View
Apr 13, 2021ANSBERT GADICKEUBS Oncology Impact Fund LPMPM Oncology Impact Management LPOncology Impact Fund Cayman Management LPMPM Oncology Impact Management GP LLC10% OWNER-200$29.99-$6.00KSELL-0.00%6.004368MApr 09View
Apr 09, 2021ANSBERT GADICKEUBS Oncology Impact Fund LPMPM Oncology Impact Management LPOncology Impact Fund Cayman Management LPMPM Oncology Impact Management GP LLC10% OWNER-57.652K$30.99-$1.30MSELL-0.95%6.004568MApr 07 - Apr 08View
Apr 09, 2021MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC10% OWNER-40.757K$30.99-$777.34KSELL-1.10%3.655906MApr 07 - Apr 08View
Apr 09, 2021MPM BIOVENTURES LPMPM BioVentures LLCMPM BioVentures GP LLC10% OWNER-40.757K$30.99-$777.34KSELL-1.10%3.655906MApr 07 - Apr 08View
Jul 30, 2020Aaron Davis—4.417259M$19.00$27.07MDERIVATIVE CONVERSION∞72.243KJul 28View
Jul 30, 2020ANSBERT GADICKEUBS Oncology Impact Fund LPMPM Oncology Impact Management GP LLCMPM Oncology Impact Management LPOncology Impact Fund Cayman Management LP—6.06222M$19.00$6.08MDERIVATIVE CONVERSION∞2.355557MJul 28View
Jul 29, 2020MPM BioVentures LPMPM BioVentures LLCMPM BioVentures GP LLC—3.706663M$19.00$3.04MDERIVATIVE CONVERSION∞25.974KJul 28View
Jul 29, 2020Boxer Capital LLCBoxer Asset Management IncJOSEPH LEWISMVA Investors LLC—4.417259M$19.00$27.07MDERIVATIVE CONVERSION∞72.243KJul 28View
Jul 29, 2020RA CAPITAL MANAGEMENT LPPeter KolchinskyRajeev Shah—4.417259M$19.00$27.07MDERIVATIVE CONVERSION∞4.417259MJul 28View
Jul 29, 2020MPM BioVentures LPLUKE EVNINTodd FoleyMPM BioVentures B LPMPM Asset Management Investors BV LLCMPM BioVentures LLCMPM BioVentures GP LLCMPM BIOVENTURES LPMPM BIOVENTURES B LPMPM ASSET MANAGEMENT INVESTORS BV LLC—3.706663M$19.00$3.04MDERIVATIVE CONVERSION∞25.974KJul 28View

FAQ

Q

Is insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

People Also Watch